Jury Awards $225K For Jaw Decay From Novartis Bone Drug
A federal jury in Missouri on Friday awarded $225,000 to a woman claiming Novartis Pharmaceuticals Corp.'s bone drug Zometa caused her mother's jaw disease, unanimously finding the drugmaker negligently failed to...To view the full article, register now.
Already a subscriber? Click here to view full article